Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) today announced that it filed a registration statement on Form S-1 with the Securities and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE